Form 990 for tax year 2024
Filed by CANCER RESEARCH AMERICA NFCR INC.
Totals
- Total revenue
- $11,095,696
- Total expenses
- $9,799,090
- Contributions and grants received
- $10,388,208
- Grants paid
- $3,614,953
- Program service revenue
- $0
- Investment income
- $691,486
- Other revenue
- $16,002
- Total assets, end of year
- $12,279,522
- Total liabilities, end of year
- $3,006,290
- Net assets or fund balances, end of year
- $9,273,232
- Program services expenses (Part IX)
- $7,278,495
- Management and general expenses
- $714,283
- Fundraising expenses
- $1,806,312
- Program service expenses (Part III)
- $7,278,495
Program services were 74.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$37,445
-
1c · Fundraising events
$353,871
-
1f · All other contributions, gifts and grants
$9,996,892
-
1g · Noncash contributions included above
$129,870
-
3 · Investment income
total $292,097 · unrelated business $0 · excluded $292,097
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $826 · excluded $826
-
6c · Rental income or loss
real property $0 · personal property $0
-
6d · Net rental income or loss
total $0
-
7a · Gross sales of assets other than inventory
securities $478,861
-
7b · Less cost or other basis and sales expenses
securities $79,472
-
7c · Gain or loss
securities $399,389
-
7d · Net gain or loss
total $399,389 · excluded $399,389
-
8a · Fundraising events: gross income
$34,704
-
8a · Fundraising events: contributions included on line 1c
$353,871
-
8b · Fundraising events: direct expenses
$55,696
-
8c · Net income from fundraising events
total -$20,992 · excluded -$20,992
-
9a · Gaming: gross income
$0
-
9b · Gaming: direct expenses
$0
-
9c · Net income from gaming
total $0
-
10a · Gross sales of inventory
$0
-
10b · Cost of goods sold
$0
-
10c · Net income from sales of inventory
total $0
-
11a · Other revenue: MAILING LIST RENTALS
total $36,168 · excluded $36,168
-
11e · Other revenue, total
$36,168
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $3,357,035 · program services $3,357,035
-
2 · Grants to domestic individuals
total $222,918 · program services $222,918
-
3 · Grants to foreign organizations and individuals
total $35,000 · program services $35,000
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $825,987 · program services $614,946 · management and general $122,708 · fundraising $88,333
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $953,675 · program services $654,490 · management and general $99,150 · fundraising $200,035
-
8 · Pension plan contributions
total $77,115 · program services $51,727 · management and general $6,601 · fundraising $18,787
-
9 · Other employee benefits
total $54,639 · program services $35,110 · management and general $8,088 · fundraising $11,441
-
10 · Payroll taxes
total $98,529 · program services $69,922 · management and general $12,162 · fundraising $16,445
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $19,500 · management and general $19,500
-
11c · Fees: accounting
total $54,833 · management and general $54,833
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $29,984 · fundraising $29,984
-
11f · Fees: investment management
total $44,973 · management and general $44,973
-
11g · Fees: other
total $523,614 · program services $237,748 · management and general $207,004 · fundraising $78,862
-
12 · Advertising and promotion
total $41,805 · program services $16,502 · management and general $23,538 · fundraising $1,765
-
13 · Office expenses
total $95,858 · program services $30,866 · management and general $57,808 · fundraising $7,184
-
14 · Information technology
total $556,264 · program services $261,790 · management and general $4,947 · fundraising $289,527
-
15 · Royalties
total $0
-
16 · Occupancy
total $236,951 · program services $164,215 · management and general $34,317 · fundraising $38,419
-
17 · Travel
total $27,231 · program services $8,146 · management and general $14,709 · fundraising $4,376
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $124,320 · program services $124,320
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $7,022 · program services $4,984 · management and general $870 · fundraising $1,168
-
23 · Insurance
total $20,307 · program services $14,414 · management and general $2,515 · fundraising $3,378
-
24a · Other expenses: DIRECT MAIL PROGRAMS
total $2,272,611 · program services $1,309,186 · fundraising $963,425
-
24b · Other expenses: LOCK BOX SERVICE
total $91,503 · program services $56,254 · fundraising $35,249
-
24c · Other expenses: PROCESS FEES-LIST SALES
total $12,855 · program services $7,947 · fundraising $4,908
-
24d · Other expenses: MISCELLANEOUS FUNDRAISING
total $14,561 · program services $975 · management and general $560 · fundraising $13,026
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $1,337 · end of year $2,799
-
2 · Savings and temporary cash investments
beginning of year $1,752,406 · end of year $1,990,757
-
3 · Pledges and grants receivable
beginning of year $0 · end of year $0
-
4 · Accounts receivable
beginning of year $51,727 · end of year $20,803
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $373,197 · end of year $199,259
-
10a · Land, buildings and equipment: cost or other basis
$230,904
-
10b · Land, buildings and equipment: accumulated depreciation
$213,386
-
10c · Land, buildings and equipment, net
beginning of year $20,192 · end of year $17,518
-
11 · Investments: publicly traded securities
beginning of year $4,826,460 · end of year $6,479,022
-
12 · Investments: other securities
beginning of year $200,442 · end of year $200,442
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $3,307,913 · end of year $3,368,922
-
17 · Accounts payable and accrued expenses
beginning of year $722,035 · end of year $813,237
-
18 · Grants payable
beginning of year $1,393,836 · end of year $1,681,280
-
19 · Deferred revenue
beginning of year $135 · end of year $135
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $736,957 · end of year $511,638
-
27 · Net assets without donor restrictions
beginning of year $4,299,106 · end of year $5,659,360
-
28 · Net assets with donor restrictions
beginning of year $3,381,605 · end of year $3,613,872
Mission and programs · 2024
Mission
SEE SCHEDULE O
Activities or mission (Part I)
TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER.
-
Scientific Advancement: In 2023-2024, NFCR funded 37 scientists conducting groundbreaking research across more than 15 cancer types. This investment fuels basic, translational, and clinical research, expanding the global knowledge base and accelerating new therapeutic approaches. Clinical Impact: NFCR-supported discoveries advanced 7 therapies into clinical trial phases (5 Phase 1, 2 Phase 2), bringing innovative treatments closer to patients in need. Innovation Translation: NFCR contributed to breakthroughs in liquid biopsy technologies for early detection and precision oncology approaches, supporting innovations that improve patient outcomes and inform prevention strategies. Public Health Outreach: In 2024, NFCR distributed over 250 Cancer Prevention Kits, directly reaching over 1000 individuals through about 100 community events nationwide. These resources empower the public to adopt cancer-preventive behaviors and pursue timely screenings. Marketing & Communications Impact: NFCR's marketing and communications strategies amplify the reach, engagement, and influence of our scientific funding and public health initiatives, ensuring that program results translate into broad awareness, donor action, and sustained mission support. Owned & social channels: NFCR runs an active content ecosystem, including a blog, and media gallery with two YouTube series (Making Sense of Science and Cancer-Fighting Lifestyle), the All Things CANCER podcast, and an email newsletter sign-up for ongoing education and donor stewardship. Public education assets: NFCR publishes accessible prevention resources, including the downloadable Cancer Prevention & Early Detection Kit and Cancer Screening Guidelines, which reinforce behavior change and early detection messaging. Thought leadership & convenings: The annual NFCR Global Summit & Award Ceremonies serve as a collaboration engine where "new partnerships form every year," expanding the impact of NFCR's science communications beyond owned channels. Fundraising communications tied to outcomes: Event communications (e.g., Daffodils & Diamonds) publicly report results linking storytelling to tangible support for research. Mission context for all outreach: NFCR consistently communicates scale and stewardship - $420M+ funded and 5.3M+ lifetime donors in progress/annual reports and "About" materials, anchoring all marketing in mission impact. Through global collaboration, NFCR is making unique impact on a new and accelerated path to cures. NFCR envisions a world without cancer!
Expenses $5,045,821 · Grants $3,614,953
-
NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 235,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.
Expenses $2,232,674
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Sujuan BaSUJUAN BA
PRESIDENT/CEO
- Total calculated
- $557,229
- From this org
- $462,395
- From related orgs
- $0
- Other
- $94,834
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $461,207
- Bonus
- $0
- Other
- $1,188
- Deferred
- $69,000
- Nontaxable benefits
- $25,834
- Filer's total
- $557,229
-
Kwok LeungKWOK LEUNG
CFO/SECRETARY
- Total calculated
- $265,443
- From this org
- $231,444
- From related orgs
- $0
- Other
- $33,999
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $226,658
- Bonus
- $2,500
- Other
- $2,286
- Deferred
- $33,999
- Nontaxable benefits
- $0
- Filer's total
- $265,443
-
Brian WachtelBRIAN WACHTEL
CHIEF DEV OFFICER/EXEC. DIR
- Total calculated
- $188,755
- From this org
- $166,208
- From related orgs
- $0
- Other
- $22,547
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $164,063
- Bonus
- $1,875
- Other
- $270
- Deferred
- $22,547
- Nontaxable benefits
- $0
- Filer's total
- $188,755
-
Zeting WangZETING WANG
SENIOR DIR OF DIRECT RESPONSE
- Total calculated
- $136,099
- From this org
- $123,693
- From related orgs
- $0
- Other
- $12,406
- Hours/week
- 40
-
Alfred SlanetzALFRED SLANETZ
CHAIR OF THE BOARD
- Total calculated
- $0
- Hours/week
- 5
-
Brian Leyland-JonesBRIAN LEYLAND-JONES
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
Judith P BarnhardJUDITH P BARNHARD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1.5
-
Karen BurkeKAREN BURKE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Franklin Salisbury JrFRANKLIN SALISBURY JR
DIRECTOR (EFF 01/31/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Silas DeaneSILAS DEANE
DIRECTOR (EFF 05/24/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Padmakumar KaimalPADMAKUMAR KAIMAL
DIRECTOR (EFF 05/24/2024)
- Total calculated
- $0
- Hours/week
- 1
-
Lance KawaguchiLANCE KAWAGUCHI
DIRECTOR (THRU 01/26/2024)
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- SCHEDULE J, PART I, LINE 7
- BONUSES PAID TO KWOK LEUNG, BRIAN WACHTEL, AND ZETING WANG ARE DETERMINED ON AN ANNUAL BASIS BY THE BOARD AND/OR MANAGEMENT OF NFCR.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$870,000
collaboration
-
MASSACHUSETTS GENERAL HOSPITAL
$352,092
RESEARCH CONTRACTS
-
$250,000
RESEARCH CONTRACTS
-
$230,000
RESEARCH CONTRACTS
-
$211,120
RESEARCH CONTRACTS
-
THE SCRIPPS RESEARCH INSTITUTE
$200,000
RESEARCH CONTRACTS
-
$152,340
RESEARCH CONTRACTS
-
RESEARCH CONTRACTS
-
MD ANDERSON CANCER CENTER
$140,000
RESEARCH CONTRACTS
-
$140,000
RESEARCH CONTRACTS
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)3 · CANCER RSRCH · DC · controlled entity
Directly controlled by NFCR
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 10 November 2025
- IRS schema version
- 2024v5.2
- Source object
- 202533149349305998
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.